A detailed history of Eqis Capital Management, Inc. transactions in Haleon PLC stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 73,069 shares of HLN stock, worth $686,117. This represents 0.06% of its overall portfolio holdings.

Number of Shares
73,069
Previous 92,436 20.95%
Holding current value
$686,117
Previous $763,000 1.31%
% of portfolio
0.06%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$8.32 - $10.7 $161,133 - $207,226
-19,367 Reduced 20.95%
73,069 $773,000
Q2 2024

Aug 13, 2024

SELL
$8.01 - $8.64 $24,005 - $25,894
-2,997 Reduced 3.14%
92,436 $763,000
Q1 2024

May 14, 2024

SELL
$8.02 - $8.67 $46,283 - $50,034
-5,771 Reduced 5.7%
95,433 $810,000
Q4 2023

Feb 14, 2024

BUY
$7.78 - $8.62 $787,367 - $872,378
101,204 New
101,204 $832,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.